DXCM240927C63000
- 7.50
- 0.000.00%
DexCom Newsroom
Investing in DexCom (NASDAQ:DXCM) Five Years Ago Would Have Delivered You a 89% Gain
Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap
'No Pain, No Gain,' Just Look at Stocks That Jumped Nearly 1,000% in a 5-year Time Span
Smart Home Healthcare Market Assessment: A Deep Dive Into Historical, Current, and Forecasted Analytics 2020-2030; Featuring Roche, Dexcom, Apollo Global Management, VitalConnect & More
Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
Dexcom Director Bridgette P. Heller Sells Shares Worth $70,000
Senseonics Eversense 365 Glucose Monitor Cleared in the U.S.
Oppenheimer Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $115
Oppenheimer analyst Steven Lichtman maintains $DexCom(DXCM.US)$ with a buy rating, and maintains the target price at $115.According to TipRanks data, the analyst has a success rate of 53.0% and a
Wells Fargo Remains a Buy on Dexcom (DXCM)
Roche Stock to Benefit From Accu-Chek Smartguide Launch in Europe
Is DexCom Stock Underperforming the S&P 500?
Three 'Buys,' Three 'Sells,' and a 'Hold,' by Oppenheimer Analysts
3 Reasons DexCom Looks Like a No-Brainer Buy Right Now
Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
Analysts' Top Healthcare Picks: Dexcom (DXCM), Ascendis Pharma (ASND)
$100 Invested In DexCom 15 Years Ago Would Be Worth This Much Today
Oppenheimer Lists Best Stock Ideas Into the 2024 U.S. Elections
Investors Will Want DexCom's (NASDAQ:DXCM) Growth In ROCE To Persist
Micron and Dexcom: 2 'Strong Buy' S&P 500 Stocks With High Upside
Jim Cramer Doesn't Like Carnival Right Now: Royal Caribbean Is 'The One You Want'